SURVIVAL ANALYSIS OF TIME TO FIRST ADVERSE DRUG REACTION AND DRUG SURVIVAL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH METHOTREXATE AND HYDROXYCHLOROQUINE MONOTHERAPIES OR COMBINATION THERAPY

被引：0
|
作者：
Velthuis, K. [1 ]
Nguyen, M. [1 ]
Scholl, J. [1 ]
Jansen, J. [1 ]
Van Lint, J. [1 ]
Ten Klooster, P. [2 ,3 ]
Vonkeman, H. [3 ,4 ]
Jessurun, N. [1 ]
机构：
[1] Netherlands Pharmacovigilance Ctr Lareb, Res Dept, sHertogenbosch, Netherlands
[2] Transparency Healthcare BV, Hengelo, Netherlands
[3] Univ Twente, Dept Psychol Hlth & Technol, Enschede, Netherlands
[4] Medisch Spectrum Twente, Dept Rheumatol & Clin Immunol, Enschede, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.181
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0648
引用
收藏
页码：562 / 563
页数：2
相关论文
共 50 条
  • [21] NEUROPSYCHIATRIC ADVERSE DRUG REACTIONS ASSOCIATED WITH LOW DOSE METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS
    Van Lint, J.
    Bakker, T.
    Ten Klooster, P.
    Vonkeman, H.
    Jessurun, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1153 - 1153
  • [22] INFLUENCE OF DIABETES MELLITUS ON DRUG SURVIVAL AND TREATMENT EFFICACY OF BIOLOGICS THERAPY IN RHEUMATOID ARTHRITIS PATIENTS
    Isono, M.
    Hirano, Y.
    Hirabara, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 182 - 182
  • [23] Obesity might not alter tofacitinib drug survival in rheumatoid arthritis patients
    Erdogan, Esra Kayacan
    Armagan, Berkan
    Ulucakoy, Rezan Kocak
    Orhan, Kevser
    Guven, Serdar Can
    Ulusoy, Bahar Ozdemir
    Konak, Hatice Ecem
    Karakas, Ozlem
    Dagli, Pinar Akyuz
    Atalar, Ebru
    Dogan, Ismail
    Maras, Yuksel
    Omma, Ahmet
    Kucuksahin, Orhan
    Erten, Sukran
    Babaoglu, Hakan
    WIENER KLINISCHE WOCHENSCHRIFT, 2025, 137 (1-2) : 49 - 55
  • [24] Drug Survival of Biologics in Rheumatoid Arthritis Patients in a Canadian Patient Cohort
    Rioux, Eve
    Rioux, Marie-Jeanne
    Fortin, Isabelle
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1457 - 1458
  • [25] Drug Survival of JAK Inhibitors and Biologic DMARDs in Rheumatoid Arthritis Patients
    Chow, Jocelyn
    Sraka, Gabrielle
    Chau, Kristie
    Soucy, Elaine
    Chow, Andrew
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 797 - 798
  • [26] EFFICACY OF COMBINATION THERAPY OF METHOTREXATE WITH HYDROXYCHLOROQUINE OR SULFASALAZINE IN RHEUMATOID ARTHRITIS PATIENTS IN KUMAON REGION: A COMPARATIVE STUDY
    Bharat, Suyash
    Srivastava, Bhavana
    Singh, Paramjeet
    Bhardwaj, Reena
    Gaur, Sanjay
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (51): : 3403 - 3407
  • [27] SIMILAR EFFICACY AND DRUG SURVIVAL RATES OF BARICITINIB MONOTHERAPY AND BARICITINIB/METHOTREXATE COMBINATION THERAPY IN REAL-LIFE TREATMENT OF RHEUMATOID ARTHRITIS - RESULTS FROM A PROSPECTIVE COHORT OF BARICITINIB-TREATED PATIENTS
    Bayat, S.
    Tascilar, K.
    Bohr, D.
    Simon, D.
    Kronke, G.
    Hartmann, F.
    Knitza, J.
    Schett, G.
    Kleyer, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 629 - 629
  • [28] DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS IN PATIENTS TREATED FOR RHEUMATOID ARTHRITIS
    Hadwan, Nawal
    Al-Wahdani, Batool
    Awadh, Basem
    Al-Allaf, Abdul-Wahab
    RHEUMATOLOGY, 2017, 56 : 188 - 189
  • [29] Guidelines for folate supplementation in rheumatoid arthritis patients treated with methotrexate: Comment on the guidelines for monitoring drug therapy - Reply
    Simms, RW
    Kwoh, CK
    Anderson, LG
    Erlandson, DM
    Greene, JM
    Moncur, C
    ODell, JR
    Partridge, AJ
    Roberts, WN
    Robbins, ML
    Yood, RA
    Liang, MH
    ARTHRITIS AND RHEUMATISM, 1997, 40 (02): : 391 - 392
  • [30] PREDICTORS OF DRUG SURVIVAL OF BDMARDS IN BIO-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS (RA) DURING THE FIRST YEAR OF THERAPY.
    Aronova, E.
    Lukina, G.
    Gridneva, G.
    Glukhova, S.
    Kudryavtseva, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1431 - 1431
12345